CHICAGO – About two years after the formation of the $471 million UBS Oncology Impact Fund (OIF), which is managed by MPM Capital, the fund is living up to its namesake, making an impact by doling out $1.25 million to a new AACR-MPM Transformative Cancer Research Grants Program and another $1.25 million to the UBS Optimus Foundation. Read More
